Robert: Pfizer requests Health Canada approval for child COVID-19 vaccine
Published on October 19th, 2021 @ 12:00 PM
Pfizer-BioNTech has submitted a request to Health Canada to approve the first COVID-19 vaccine for children aged 5 to 11 years old.
Pfizer has already submitted clinical trial data for its child-sized dose to Health Canada, and the company says the results were comparable to those recorded in the Pfizer-BioNTech study in people aged 16 to 25.
“Health Canada will only authorize the use of Comirnaty (Pfizer COVID-19 vaccine) if the independent and thorough scientific review of all the data included in the submission showed that the benefits of the vaccine outweighed the potential risks in this age group,” a statement from Health Canada reads.
The doses are said to be about one-third the size given to adults and teens.
Continuing, Health Canada says it will prioritize the review of the submission, while maintaining high scientific standards for safety, efficacy and quality.
As soon as the shot gets the thumbs up, providers will technically be able to start offering the COVID-19 shot to kids, though new child-sized doses might need to be procured.
After approval, the National Advisory Committee on Immunization will give their recommendations on whether the benefits of the shot outweigh potential risks.